Literature DB >> 21309054

Alterations of platelet biochemical and functional properties in newly diagnosed type 1 diabetes: a role in cardiovascular risk?

Arianna Vignini1, Cinzia Moroni, Laura Nanetti, Francesca Raffaelli, Annamaria Cester, Orazio Gabrielli, Valentino Cherubini, Laura Mazzanti.   

Abstract

BACKGROUND: The involvement of platelets in the pathogenesis of diabetic vascular complications is supported by several studies. Type 1 diabetic (T1D) platelets show increased adhesiveness and aggregation related to a modification of nitric oxide synthase activity. Moreover, different cell types from diabetic patients showed a decreased membrane Na(+) /K(+) -ATPase activity, which might be involved in diabetic complications. The aim of this study was to investigate whether T1D at onset is able to induce alterations of platelet physicochemical and functional properties and whether these changes are affected by hyperglycaemia.
METHODS: The study was performed on 50 young subjects: 30 patients (1-14 years) affected by T1D and 20 age- and gender-matched healthy subjects. We analyzed platelet membrane fluidity by fluorescent anisotropy of 1-(4-trimethylaminophenyl)-6-phenyl-1,3,5-hexatriene and 1,6-diphenyl-1,3,5-hexatriene, Na(+) /K(+) -ATPase, nitric oxide, and peroxynitrite production.
RESULTS: In T1D subjects, we observed an increased fluidity in the plasma membrane outer part and greater rigidity in the internal part compared with that in controls. Na(+) /K(+) -ATPase activity and nitric oxide levels were significantly reduced, while peroxynitrite production was increased compared with that in controls. Moreover, correlations found between the above parameters were correlated with fasting glycaemia and haemoglobin A(1c).
CONCLUSIONS: T1D patients exhibit structural and functional modifications of platelet membrane properties and alterations of nitric oxide metabolism due to diabetes per se and not to chronic hyperglycaemia, insulin therapy, or ageing. These results support the hypothesis that oxidative attack could be an important early event in the pathogenesis of diabetic complications.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309054     DOI: 10.1002/dmrr.1173

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

Review 1.  Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets.

Authors:  Rebecca C Sagar; Ramzi A Ajjan; Khalid M Naseem
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

2.  Platelet profile in patients with gestational diabetes: a retrospective study.

Authors:  Muhammet Erdal Sak; Hatice Ender Soydinç; Ali Ozler; Mehmet Sıddık Evsen; Abdülkadir Turgut; Sibel Sak; Talip Gül
Journal:  J Turk Ger Gynecol Assoc       Date:  2012-12-01

3.  Novel African trypanocidal agents: membrane rigidifying peptides.

Authors:  John M Harrington; Chris Scelsi; Andreas Hartel; Nicola G Jones; Markus Engstler; Paul Capewell; Annette MacLeod; Stephen Hajduk
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

Review 4.  Mucormycosis: A triple burden in patients with diabetes during COVID-19 Pandemic.

Authors:  A S Fathima; Vakada Lakshmi Mounika; V Udaya Kumar; Ashok Kumar Gupta; Pavan Garapati; V Ravichandiran; Sameer Dhingra; Krishna Murti
Journal:  Health Sci Rev (Oxf)       Date:  2021-12-03

5.  Platelet Dysfunction in Type 1 Diabetes: Stressing the Thromboxanes.

Authors:  Jaclyn A Wisinski; Michelle E Kimple
Journal:  Diabetes       Date:  2016-02       Impact factor: 9.461

6.  Platelet Activation and Platelet-Leukocyte Aggregates in Type I Diabetes Mellitus.

Authors:  Asmaa M Zahran; Omnia El-Badawy; Ismail L Mohamad; Deiaaeldin M Tamer; Safwat M Abdel-Aziz; Khalid I Elsayh
Journal:  Clin Appl Thromb Hemost       Date:  2018-10-11       Impact factor: 2.389

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.